Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
acetylsalicylic acid (aspirin) (1 trial)
ticagrelor (brilinta) (2 trials)
ixekizumab (taltz) (1 trial)
epinephrine (levophed) (1 trial)
metoprolol (lopressor) (1 trial)
Acute Coronary Syndrome (Phase 4)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Syndrome (Phase 4)
Trials (3 total)
Trial APIs (5 total)